This integrated approach addresses aging from multiple angles, creating synergistic benefits that exceed what any single therapy could achieve alone
This is the same mechanism used by the bodys own GHRH, which means sermorelin: Preserves the natural pulsatile pattern of GH release Maintains somatostatin feedback inhibition Supports long-term pituitary function rather than suppressing it Works synergistically with exercise and sleep, which naturally enhance GHRH signaling Clinical History Sermorelin has a notable clinical history
MK-677 (Ibutamoren) MK-677 (ibutamoren) is an orally active, non-peptide small molecule agonist of the ghrelin receptor (GHSR-1a) that stimulates endogenous growth hormone and IGF-1 secretion, studied in randomized trials in older adults, obesity, and sleep research
Most peptides work by signaling your bodys own hormone production rather than introducing synthetic hormones directly which is one of the reasons they tend to have a more favorable safety profile
With adequate monitoring, your therapy will support your long-term wellness goals too
Instead of introducing a synthetic growth hormone into your body, CJC 1295 and Ipamorelin work by gently signaling your own pituitary gland to produce and release more of its own growth hormone
